Search the Newsreel

Renaissance Technologies LLC Buys 412,700 Shares of Bicycle Therapeutics PLC Sponsored ADR $BCYC

Renaissance Technologies LLC significantly increased its stake in Bicycle Therapeutics PLC (NASDAQ:BCYC) by 72.8%, acquiring an additional 412,700 shares to own a total of 979,300 shares, representing approximately 1.4% of the company. This move comes amidst mixed analyst ratings and Bicycle Therapeutics reporting a …

Five candidates put forward for Pure Cycle’s 2027 board vote

Pure Cycle Corporation announced it received a notice from Maran Partners Fund, LP, nominating five individuals for election to its Board of Directors at the 2027 Annual Meeting of Shareholders. The company's Nominating and Corporate Governance Committee will review these nominees, and the Board …

PureCycle Technologies, Inc. Stock 12‑Month Price Target Cut to $11.5, Implies 67% Upside

PureCycle Technologies, Inc.'s average 12-month price target has been reduced from $12.17 to $11.5 by six analysts, with individual forecasts ranging from $6 to $17 per share. This new target suggests a potential upside of approximately 67% based on the August 6 closing price. …

PureCycle Technologies, Inc. reports results for the quarter ended June 30 - Earnings Summary

PureCycle Technologies, Inc. has released its earnings summary for the quarter that concluded on June 30. The article is a brief announcement from Refinitiv, distributed through TradingView News, providing access to the full report for subscribers.

PureCycle increases revenue in Q3

PureCycle Technologies Inc. reported a significant revenue increase of 173 percent in the second quarter of 2026, reaching over $4.5 million, though it continued to operate at a net loss of $142.2 million. The company has started commercial resin deliveries to Procter & Gamble …

Price to sales forward of PureCycle Technologies, Inc. – NASDAQ:PCTTU

This article provides financial information for PureCycle Technologies, Inc. (NASDAQ: PCTTU), specifically focusing on its forward price-to-sales ratio. The content is presented within the TradingView platform, offering an overview of the company's financials to users.

Bicycle Therapeutics PLC (BCYC) Earnings Forecast: Future EPS & Revenue Growth Estimates

Cycurion Confirms August 20 Nasdaq Hearing Date; Common Stock Continues Trading on Nasdaq

Cycurion announced that its common stock continues to trade on the Nasdaq Capital Market and has not been delisted, despite a pending hearing with the Nasdaq Hearings Panel. The hearing is scheduled for August 20, 2026, and the company stated it will provide updates …

Jardine Cycle & Carriage (SGX:C07) Could Be 6% Undervalued As Special Dividend Lands

Cycurion decides against 7-for-1 reverse stock split

Cycurion Inc. has announced its board and management will not proceed with a proposed 7-for-1 reverse stock split, citing concerns that it would harm shareholders and fail to address underlying issues. CEO Kevin Kelly highlighted the company's recent acquisitions, revenue growth, and a ten-year …

PureCycle lands P&G packaging wins as recycled PP demand builds

PureCycle Technologies Inc. has secured packaging contracts with Procter & Gamble for its recycled polypropylene. This development highlights the growing demand for recycled plastics, particularly as PureCycle's Ironton, Ohio, facility is now equipped with in-house compounding operations to support these efforts. The article also …

Nupur Recyclers Insiders May Regret Not Buying More, Market Cap Hits ₹8.0b

Revenue Miss: Jain Resource Recycling Limited Fell 9.3% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Unicycive Therapeutics (UNCY) Projected to Post Quarterly Earnings on Thursday

Unicycive Therapeutics (NASDAQ:UNCY) is expected to announce its Q2 2026 earnings before market open on Thursday, August 13th, with analysts forecasting a loss of $0.471 per share and revenue of $22.2 million. This follows a Q1 loss of $0.54 per share, which missed estimates. …

Cyclerion Therapeutics (CYCN) outlines terms, risks and disclosures for proposed Korsana merger

Cyclerion Therapeutics (CYCN) has detailed the terms, risks, and disclosures for its proposed merger with Korsana Biosciences in a recent Form 425 SEC filing. The merger involves two Cyclerion subsidiaries merging with Korsana, with the transaction contingent on Cyclerion stockholder approval, regulatory clearances, and …

PureCycle Technologies, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:PCT) 2026-08-06

This article announces that PureCycle Technologies, Inc. has published its slide deck in conjunction with its 2026 Q2 earnings call. The content is an earnings call presentation for the company, traded under the NASDAQ symbol PCT. It was published on August 6, 2026, by …

PureCycle Technologies (NASDAQ:PCT) Shares Decline on Q2 Revenue and EPS Miss

PureCycle Technologies (NASDAQ:PCT) reported lower-than-expected Q2 2026 revenue of $4.5 million and a wider non-GAAP loss per share of $0.33, leading to a 10.3% drop in after-hours trading. Despite missing analyst forecasts, the company noted several operational milestones, including initial commercial deliveries to Procter …

PureCycle Technologies Reports Second Quarter 2026 Results

PureCycle Technologies announced its Q2 2026 results, reporting $4.5 million in revenue, a 173% year-over-year increase, and significant commercial progress with new customer conversions and product deliveries to P&G. The company completed a planned turnaround at its Ironton facility ahead of schedule, began on-site …

PureCycle Technologies (Nasdaq: PCT) posts Q2 2026 $4.5M revenue, $142.2M loss and $236.9M liquidity

PureCycle Technologies reported Q2 2026 results, with revenue growing 173% year-over-year to $4.5 million, though the company remained loss-making with a net loss of $142.2 million. The company improved its liquidity to $236.9 million following June offerings of convertible senior notes and common shares. …

Pure Cycle Corp (PCYO) holder Maran nominates 5 directors with 14.7% stake

Maran Capital Management and related investment entities, holding a combined 14.7% stake in Pure Cycle Corp (PCYO), have nominated five candidates for election to Pure Cycle's board of directors at the 2027 annual meeting. This move is detailed in an amended Schedule 13D filing, …

PureCycle Technologies, Inc. (PCT) Reports Q2 Loss, Misses Revenue Estimates

PureCycle Technologies (PCT) reported a Q2 loss of $0.33 per share, missing the Zacks Consensus Estimate of a $0.26 loss. The company also missed revenue estimates, posting $4.51 million against an expectation of $7.45 million. The stock currently holds a Zacks Rank #4 (Sell), …

Purecycle Technologies earnings up next: Can revenue offset losses? By Investing.com

Purecycle Technologies is set to release its second-quarter earnings, with investors focused on whether increased revenue can mitigate widening losses as the company navigates a critical commercialization phase. Analysts expect a loss of $0.29 per share on $5.81 million in revenue. The company faces …

PureCycle Technologies (NASDAQ: PCT) adds $288M converts, posts $142M loss

PureCycle Technologies (PCT) Earnings Date and Reports 2026 $PCT

Behavioral Patterns of PCT and Institutional Flows

This article analyzes Purecycle Technologies Inc. (NYSE: PCT) using AI models, identifying a positive near-term sentiment that may shift. It highlights a critical support test, an exceptional risk-reward setup, and divergent sentiment across time horizons. The report provides three distinct institutional trading strategies for …

Cyclerion Therapeutics (NASDAQ: CYCN) outlines Korsana merger and going concern risk

Cyclerion Therapeutics (NASDAQ: CYCN) has reported its Q2 2026 financials, showing $1.391 million in cash and cash equivalents, a net loss of $4.932 million for the first half of 2026, and no revenue. The company has identified substantial doubt about its ability to continue …

Price to earnings forward of PureCycle Technologies, Inc. – BOATS:PCTTU

This article focuses on the forward price-to-earnings ratio for PureCycle Technologies, Inc. (BOATS:PCTTU). It appears to be a financial data page from TradingView, displaying the stock information and financial metrics for the company. The content also mentions the data sources and copyright information.

Jardine Cycle & Carriage to Liquidate Two Myanmar Subsidiaries

Cycurion, Inc. Closes Acquisition of Digital

Cycurion, Inc. has announced the completion of its acquisition of Digital. This strategic move aims to enhance Cycurion's capabilities and market position in the digital sector. Further details about the acquisition's impact on company operations and offerings are expected.

Cycurion (NASDAQ: CYCU) adds $5M+ revenue and 800 clients with Kustom deal

Cycurion (NASDAQ: CYCU) has successfully acquired the Digital Ally video-solutions business from Kustom Entertainment, a move expected to add over $5 million in annual revenue and more than $1.2 million in EBITDA, boosting Cycurion's gross revenue run rate to approximately $30 million. This strategic …

Cyclerion Therapeutics 2Q 2026: Revenue $0 Net loss $(1.76M) — 10-Q Summary

Cyclerion Therapeutics reported zero revenue and a net loss of $(1.755M) for Q2 2026, a significant change from the previous year. The company is undergoing a merger with Korsana, expected to close in Q3 2026, and is focusing on pipeline monetization and specific drug …

BCYC|Bicycle Therapeutics PLC|Price:3.875|Chg%:+0.015

Bicycle Therapeutics PLC (BCYC) shows strong fundamentals and significant growth potential, despite recent weak market performance. TradingKey's analysis rates its valuation as fairly valued, with high institutional ownership. Analysts have given the stock a "Buy" rating, setting a high price target, though the stock …

Cyclerion (CYCN) and Korsana add leaders as reverse merger targets Q3 2026 close

Cyclerion Therapeutics (CYCN) and Korsana Biosciences announced progress on their reverse merger, which is still expected to close in Q3 2026. Korsana has strengthened its leadership team with new appointments, including Matthew Leoni as Chief Medical Officer, Gan Wei as Chief Technical Officer, and …

PureCycle Technologies, Inc. Revenue Breakdown – BOATS:PCTTU

This article provides a financial overview of PureCycle Technologies, Inc. (PCTTU) on TradingView, focusing on its revenue breakdown. It outlines sections for financials, news, community, forecasts, and various fundamental statistics like earnings and segments. The content emphasizes the availability of detailed financial data and …

Jain Resource Recycling Q1 FY27 Revenue Surges 76% to ₹2,724 Cr; Margins Moderate

PureCycle 24 Hour Deadline Alert

Faruqi & Faruqi, LLP is investigating potential claims against PureCycle Technologies, Inc. (NASDAQ: PCT) and reminds investors of the November 28, 2023 deadline to seek the role of lead plaintiff in a federal securities class action. The lawsuit alleges that PureCycle made misleading statements …